相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Novel Mouse Model of Atherosclerotic Plaque Instability for Drug Testing and Mechanistic/Therapeutic Discoveries Using Gene and MicroRNA Expression Profiling
Yung-Chih Chen et al.
CIRCULATION RESEARCH (2013)
Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes
Oliver Soehnlein et al.
EMBO MOLECULAR MEDICINE (2013)
The Phenotype of Infiltrating Macrophages Influences Arteriosclerotic Plaque Vulnerability in the Carotid Artery
Kyu Yong Cho et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2013)
Endogenous Renovascular Hypertension Combined With Low Shear Stress Induces Plaque Rupture in Apolipoprotein E-Deficient Mice
Shu-xuan Jin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Fractalkine: A Survivor's Guide Chemokines as Antiapoptotic Mediators
Gemma E. White et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
Stefania Momi et al.
CARDIOVASCULAR RESEARCH (2012)
Novel anti-inflammatory strategies in atherosclerosis
Fleur M. van der Valk et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway
Liu-hua Hu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Gaelle Naert et al.
MOLECULAR MEDICINE (2012)
Fractalkine - a local inflammatory marker aggravating platelet activation at the vulnerable plaque
Ulrike Flierl et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Fractalkine/CX3CR1 and atherosclerosis
Hong Liu et al.
CLINICA CHIMICA ACTA (2011)
Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
Anna K. Clark et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation
Maya R. Jerath et al.
THROMBOSIS JOURNAL (2010)
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival
Limor Landsman et al.
BLOOD (2009)
CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden
Peng Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells
Ling-Hon Shen et al.
ATHEROSCLEROSIS (2008)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury
Peng Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-γ ligands -: Putative contribution of Rho GTPases in statin-induced CD36 expression
N Ruiz-Velasco et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro
R Kleemann et al.
BLOOD (2004)
Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering
F Bea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Modulation of inflammatory mediators and PPARγ and NFκB expression by pravastatin in response to lipoproteins in human monocytes in vitro
I Zelvyte et al.
PHARMACOLOGICAL RESEARCH (2002)
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
G Martin et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
